Evidence map›Paper›PMID 28330218›Full record

Review3 Biotech2016

Bacterial carrageenases: an overview of production and biotechnological applications.

Prakram Singh Chauhan, Arunika Saxena

Open access · hybridAbstract readReview
In one paragraph

Review in 3 Biotech, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Carrageenan FromFrontiers in plant science · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Marine Polysaccharides: Occurrence, Enzymatic Degradation and Utilization.Chembiochem : a European journal of chemical biology · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. A Colorimetric pH Sensor Based onSensors (Basel, Switzerland) · 2019
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Prakram Singh ChauhanFaculty of Pharmacy and Pharmaceutical Sciences, Monash University Parkville Campus, 381, Royal Parade, Melbourne, VIC, 3052, Australia. drprakramsingh@gmail.com.
Arunika SaxenaDepartment of Chemistry, Samrat Prithviraj Chauhan Government College, Beawar Road, Ajmer, Rajasthan, India.
Government Medical College · INMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carrageenan, one of the phycocolloids is a sulfated galactan made up of linear chains of galactose and 3,6-anhydrogalactose with alternating α-(1 → 3) and β-(1 → 4) linkages and further classified based on the number and the position of sulfated ester(s); κ-, ι- and λ-carrageenan. Enzymes which degrade carrageenans are called k-, ι-, and λ-carrageenases. They all are endohydrolases that cleave the internal β-(1-4) linkages of carrageenans yielding products of the oligo-carrageenans. These enzymes are produced only by bacteria specifically gram negative bacteria. Majority of the marine bacteria produce these enzymes extracellularly and their activity is in wide range of temperature. They have found potential applications in biomedical field, bioethanol production, textile industry, as a detergent additive and for isolation of protoplast of algae etc. A comprehensive information shall be helpful for the effective understanding and application of these enzymes. In this review exhaustive information of bacterial carrageenases reported till date has been done. All the aspects like sources, production conditions, characterization, cloning and- biotechnological applications are summarized.

Indexed as

Bacterial carrageenaseBiotechnological applicationsCarrageenanGlycoside hydrolase

Identifiers

PMID28330218
PMCPMC4919138
OpenAlexW2465672045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.